<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03816592</url>
  </required_header>
  <id_info>
    <org_study_id>GUINOT 2019</org_study_id>
    <nct_id>NCT03816592</nct_id>
  </id_info>
  <brief_title>Opioid Free Anaesthesia in Cardiac Surgery With Cardiopulmonary Bypass</brief_title>
  <acronym>OFACAR 1</acronym>
  <official_title>Opioid Free Anaesthesia in Cardiac Surgery With Cardiopulmonary Bypas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since the 1990s, the concept of anesthesia without morphine (OFA) has been developed. The
      principle is based on the fact that in a sleeping patient a sympathetic reaction marked by
      hemodynamic changes does not reflect a painful phenomenon, that a painful phenomenon in a
      sleeping patient is not memorized, that hormonal stress, sympathetic reaction and
      inflammatory reaction can be controlled by therapeutic classes other than a morphine agent.
      This therapeutic management would avoid the side effects associated with the use of morphine.
      In cardiac surgery, no studies have evaluated the effect of an OFA on morphine consumption
      and on a post-operative composite endpoint. Lidocaine was only studied in the context of
      cardioprotection and neuroprotection. Studies found a cardioprotective effect with a decrease
      in episodes of rhythmic disorders, and neuroprotective with a non-constant improvement in
      postoperative cognitive functions, but all these studies were performed during opioid
      anaesthesia (opioid agent use)/ The purpose of our study is to demonstrate that general
      anesthesia without opioid (OFA) is associated with a decrease in post-operative morphine
      consumption and an improvement in the patient's post-operative well-being (complications,
      confusion, vigilance, length of stay).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">March 31, 2019</completion_date>
  <primary_completion_date type="Actual">March 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Morphine consumption</measure>
    <time_frame>Day 2</time_frame>
    <description>Total morphine consumption over the first 48 post operative hours in milligrammes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complications</measure>
    <time_frame>Day 7</time_frame>
    <description>composite end point of post operative complications (cardiac, neurological, renal, respiratory)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">110</enrollment>
  <condition>Opioid Free Anaesthesia</condition>
  <condition>Opioid Anaesthesia</condition>
  <arm_group>
    <arm_group_label>Opioid free anaesthesia</arm_group_label>
    <description>patient anesthtesized with lidocaine, ketamine and dexamethasone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Opioid anaesthesia</arm_group_label>
    <description>patients anesthetized with sufentanil ketamine and dexamethasone</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Opioid free anaesthesia</intervention_name>
    <description>patient anesthtesized with lidocaine, ketamine and dexamethasone</description>
    <arm_group_label>Opioid free anaesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Opioid anaesthesia</intervention_name>
    <description>patients anesthetized with sufentanil ketamine and dexamethasone</description>
    <arm_group_label>Opioid anaesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Cardiac surgical
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age over 18 years

          -  cardiac surgery with cardiopulmonary bypass

        Exclusion Criteria:

          -  patient with chronic analgesia treatment

          -  patient on antidepressive therapy

          -  gabapentin use

          -  preoperative cognitive dysfunction

          -  patient treated with zyvoxid
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chu Dijon Bourogne</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>January 22, 2019</study_first_submitted>
  <study_first_submitted_qc>January 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2019</study_first_posted>
  <last_update_submitted>May 17, 2019</last_update_submitted>
  <last_update_submitted_qc>May 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Opioid</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

